Corporate Overview

Devonian Health Group Inc. is a Canadian publicly traded (TSXv:GSD; OTCQB: DVHGF) clinical-stage pharmaceutical company specializing in the development of drugs for a range of autoimmune and fibroinflammatory conditions, using novel therapeutic approaches to address unmet medical needs.

Devonian Health Group Inc. core strategy is to develop prescription drugs that act on multiple cellular pathways and downregulate genes involved in autoimmune fibroinflammatory diseases, including but not limited to gastrointestinal, dermatological, and hepatologic conditions.

Based on more than 20 years of research, Devonian Health Group Inc. focus is further reinforced by a set of U.S. Food and Drug Administration regulatory guidelines that provide a more efficient development pathway for prescription botanical drug products compared to traditional prescription medicines.

Devonian Health Group Inc. is also engaged in the development of high-value cosmeceutical products, leveraging the same proprietary approach used in its pharmaceutical programs.

In addition, Devonian Health Group Inc. operates a drug distribution division, Altius Healthcare Group LP, which focuses on selling prescription pharmaceutical products in Canada under license from brand-name pharmaceutical companies.

Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada, where it owns a state-of-the-art extraction facility.

Mission / Vision

At Devonian Health Group Inc., our mission is to transform scientific research into innovative and effective therapeutic solutions aimed at improving patients’ quality of life worldwide. We are committed to conducting cutting-edge research to discover and develop treatments that address unmet medical needs. Our approach is grounded in ethics, safety, and efficacy, ensuring that every product we develop meets the highest standards of the pharmaceutical industry.

We strive to:

  • Innovate: Develop drugs offering unique and less invasive therapeutic options.
  • Collaborate: Partner with researchers, academic institutions, and industry stakeholders to accelerate the development and commercialization of our products.
  • Respect: Uphold the highest standards of integrity and respect in all our relationships with patients, employees, partners, and communities.

Our vision is to become a global leader for our ability to deliver innovative, high-quality therapeutic solutions.

Our long-term objectives include:

  • Excellence: Continue investing in research and development to maintain a leadership position in pharmaceutical innovation.
  • Growth: Expand our product portfolio to address a wide range of medical conditions while entering new international markets.
  • Responsibility: Operate as a socially responsible company by minimizing our environmental impact and contributing positively to the communities in which we operate.

By achieving our mission and vision, we aim not only to improve patient health but also to set higher standards across the entire pharmaceutical industry.